AbCellera Biologics reported a net margin of -1,368.57% for the quarter ended Jun 2026. These financial ratios cover 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||
| Gross Margin | 100.00% | 84.29% | 85.90% | 88.65% | 85.17% | 92.87% | 100.00% | 100.00% | 100.00% | 100.00% | ||||||||||||||||
| EBT Margin | -453.38% | 60.80% | 72.91% | -15.00% | 45.95% | -145.80% | -394.91% | -377.92% | -595.18% | -529.49% | -429.45% | -658.02% | -962.53% | -927.31% | -1,251.10% | -212.74% | -767.93% | -43.47% | -595.75% | -1,455.93% | ||||||
| EBIT Margin | -510.09% | 58.53% | 71.06% | -18.29% | 37.22% | -175.34% | -532.10% | -511.03% | -831.79% | -719.61% | -551.48% | -1,276.17% | -1,439.42% | -1,440.69% | -1,479.57% | -290.24% | -851.79% | -63.72% | -691.75% | -1,550.05% | ||||||
| EBITDA Margin | -510.09% | 58.53% | 71.50% | -13.28% | 39.69% | -162.40% | -508.32% | -481.20% | -784.82% | -677.12% | -519.33% | -1,229.74% | -1,381.02% | -1,399.11% | -1,375.47% | -263.32% | -803.77% | -52.27% | -620.58% | -1,399.43% | ||||||
| Operating Margin | -510.09% | 58.53% | 71.06% | -18.29% | 37.22% | -175.34% | -532.10% | -511.03% | -831.79% | -719.61% | -551.48% | -1,276.17% | -1,439.42% | -1,440.69% | -1,479.57% | -290.24% | -851.79% | -63.72% | -691.75% | -1,550.05% | ||||||
| Net Margin | -388.16% | 43.03% | 53.25% | -14.78% | 26.26% | -138.75% | -328.99% | -303.58% | -433.55% | -513.67% | -407.98% | -504.30% | -785.42% | -677.43% | -1,077.24% | -203.27% | -637.84% | -19.94% | -519.12% | -1,368.57% | ||||||
| FCF Margin | -263.36% | -18.76% | 27.08% | 526.37% | -137.40% | 86.25% | -484.31% | -72.57% | -309.70% | -370.87% | -661.52% | -683.82% | -728.42% | -467.92% | -523.97% | -267.91% | -687.01% | -99.40% | -449.24% | 587.43% | ||||||
| Efficiency | ||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 1,162.29M | 1,245.65M | 1,455.43M | 1,593.04M | 1,573.10M | 1,546.66M | 1,519.41M | 1,517.54M | 1,524.68M | 1,500.14M | 1,475.60M | 1,437.79M | 1,402.65M | 1,376.69M | 1,352.38M | 1,373.13M | 1,379.03M | 1,356.47M | 1,332.03M | 1,307.34M | ||||||
| Invested CapitalInvested Cap. | 965.52M | 1,048.67M | 1,235.01M | 1,247.11M | 1,282.70M | 1,277.49M | 1,251.38M | 1,249.70M | 1,236.70M | 1,202.79M | 1,181.34M | 1,130.99M | 1,098.31M | 1,064.17M | 1,031.75M | 1,007.08M | 964.04M | 966.90M | ||||||||
| Asset Utilization RatioAsset Util. | 0.38 | 0.30 | 0.34 | 0.32 | 0.38 | 0.31 | 0.12 | 0.10 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.06 | 0.06 | 0.05 | ||||||
| Leverage & Solvency | ||||||||||||||||||||||||||
| Debt Ratio | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | |||||||||||
| Valuation | ||||||||||||||||||||||||||
| Price to EarningsP/E | -263.53 | 67.57 | 16.46 | -447.43 | 106.15 | -97.74 | -53.92 | -60.70 | -46.12 | -35.56 | -32.44 | -23.31 | -14.80 | -25.55 | -14.46 | -29.21 | -26.33 | -114.93 | -24.57 | -43.40 | ||||||
| Price to SalesP/S | 0.00M | 29.07 | 8.76 | 66.12 | 27.88 | 135.61 | 177.40 | 184.27 | 199.96 | 182.65 | 132.35 | 117.55 | 116.20 | 173.11 | 155.74 | 59.38 | 167.95 | 22.92 | 127.57 | 594.02 | ||||||
| Price to BookP/B | 5.91 | 3.95 | 2.30 | 2.50 | 2.26 | 2.37 | 1.79 | 1.55 | 1.12 | 1.45 | 1.17 | 0.77 | 0.70 | 0.83 | 0.64 | 1.01 | 1.56 | 1.06 | 1.13 | 2.68 | ||||||
| Enterprise Value | 5,116.59M | 3,302.60M | 1,988.03M | 2,013.54M | 1,957.98M | 2,010.28M | 1,366.37M | 1,057.37M | 533.68M | 890.99M | 594.41M | 165.49M | 88.01M | 223.57M | 29.27M | 436.37M | 983.36M | 469.23M | 531.04M | 1,840.68M | ||||||
| EV to EBIT | -182.11 | 40.50 | 8.84 | -239.82 | 51.89 | -53.21 | -21.06 | -20.58 | -9.72 | -13.49 | -10.83 | -1.77 | -0.94 | -3.07 | -0.47 | -8.80 | -12.89 | -16.42 | -9.23 | -29.32 | ||||||
| EV to EBITDA | -182.11 | 40.50 | 8.78 | -330.31 | 48.66 | -57.45 | -22.05 | -21.85 | -10.30 | -14.34 | -11.50 | -1.84 | -0.98 | -3.16 | -0.50 | -9.70 | -13.66 | -20.02 | -10.29 | -32.48 | ||||||
| Market Capitalization | 5,634.28M | 4,050.58M | 2,774.08M | 3,035.81M | 2,826.18M | 2,921.76M | 2,162.86M | 1,853.06M | 1,319.52M | 1,676.58M | 1,317.44M | 860.84M | 756.14M | 874.18M | 659.54M | 1,014.45M | 1,504.03M | 1,028.05M | 1,060.77M | 2,405.79M | ||||||
| Price to FCFP/FCF | -388.41 | -154.95 | 32.36 | 12.56 | -20.29 | 157.24 | -36.63 | -253.91 | -64.57 | -49.25 | -20.01 | -17.19 | -15.95 | -36.99 | -29.72 | -22.16 | -24.45 | -23.06 | -28.40 | 101.12 | ||||||
| EV to FCF | -352.72 | -126.33 | 23.19 | 8.33 | -14.06 | 108.18 | -23.14 | -144.88 | -26.11 | -26.17 | -9.03 | -3.30 | -1.86 | -9.46 | -1.32 | -9.53 | -15.98 | -10.52 | -14.22 | 77.37 | ||||||
| EV to CFO | -862.54 | -197.62 | 19.84 | 7.38 | -15.44 | 65.03 | -31.01 | 53.13 | -0.01M | -45.43 | -14.25 | -5.52 | -3.05 | -27.95 | -2.53 | -13.47 | -18.70 | -13.51 | -15.84 | 71.01 | ||||||
| Return Ratios | ||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -510.09% | 58.53% | 71.06% | -18.29% | 37.22% | -175.34% | -532.10% | -511.03% | -831.79% | -719.61% | -551.48% | -1,276.17% | -1,439.42% | -1,440.69% | -1,479.57% | -290.24% | -851.79% | -63.72% | -691.75% | -1,550.05% | ||||||
| Return on Capital Employed [ROCE]ROCE | 25.50% | 18.18% | 21.85% | 19.68% | 22.89% | 15.16% | -5.13% | -8.32% | -14.77% | -17.17% | -16.58% | -19.69% | -23.28% | -24.21% | -25.26% | -21.34% | -19.94% | -16.80% | -16.50% | -17.95% | ||||||
| Return on Invested Capital [ROIC]ROIC | 14.22% | 16.87% | 15.37% | 18.56% | 11.21% | -7.30% | -9.68% | -13.84% | -16.36% | -16.61% | -19.97% | -24.03% | -23.66% | -24.53% | -22.78% | -22.21% | -18.54% | |||||||||
| Return on Assets [ROA]ROA | 21.91% | 12.32% | 14.07% | 12.58% | 15.79% | 10.25% | -3.30% | -4.87% | -8.47% | -9.76% | -9.96% | -10.66% | -12.53% | -11.83% | -12.41% | -12.06% | -12.45% | -10.79% | -10.81% | -12.59% |